Skip to main content
[Preprint]. 2021 Nov 11:2021.11.10.21266139. [Version 1] doi: 10.1101/2021.11.10.21266139

Figure 4:

Figure 4:

Percentage of deaths averted (compared to a baseline of no antiviral treatment) for A) Kenya, B) Mexico, C) United States and D) Belgium for early (within the first two days of symptoms, left column) or late (between days 2 and 5 of symptoms, right column) treatment. For each country, we considered four possible values of AVE (25, 50, 75 or 100% reduction in viral load) and covering 10–100% of eligible symptomatic individuals.